Format

Send to

Choose Destination
Braz J Otorhinolaryngol. 2007 Nov-Dec;73(6):843-847. doi: 10.1016/S1808-8694(15)31181-2.

Mucosal leishmaniasis: epidemiological and clinical aspects.

Author information

1
Associate researcher in the immunology and otorhinolaryngology units of the HUPES at the Federal University of Bahia. Doctor of sciences in otorhinolaryngology at FMUSP. Fellow in nasosinusal endoscopic surgery, Graz university, Austria. Electronic address: imuno@ufba.br.
2
Adjunct professor of otorhinolaryngology of the Medical School of the Federal University of Bahia. Head of the otorhinolaryngology unit of the HUPES.
3
Medical resident in the otorhinolaryngology unit of the HUPES Federal University of Bahia.
4
Adjunct professor of the biointeraction department of the Health Science Institute of the Federal University of Bahia.
5
Associate researcher in the immunology unit of the HUPES at the Federal University of Bahia.
6
Full professor in the internal medicine department of the Medical School of the Federal University of Bahia. Head of the immunology unit of the HUPES.

Abstract

Leishmaniasis has been documented in several countries, with an estimated prevalence of 12 million people and an incidence at around 400,000 new cases per year. Leishmaniasis in the New World is one the major endemic diseases in Brazil and Latin America.

OBJECTIVE:

The aim of this study was to add to the current knowledge on mucosal leishmaniasis, bringing the experience of the Immunology and Otolaryngology Departments in the Professor Edgar Santos University Hospital of the Federal University of Bahia.

CONCLUSION:

Cutaneous leishmaniasis is the most common form of New World Leishmaniasis; mucosal legions may occur simultaneously or after years of disease. Mucosal leishmaniasis is caused mainly by L. braziliensis braziliensis; although the nasal mucosa is the most affected area, lesions may be found on the lips, mouth, pharynx and larynx. In addition to parasite-related factors, the host immune response may be involved in the pathogenicity of lesions in mucosal leishmaniasis.

PMID:
18278231
DOI:
10.1016/S1808-8694(15)31181-2
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center